alpidem has been researched along with Anxiety Neuroses in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (27.27) | 18.7374 |
1990's | 8 (72.73) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
O'Hanlon, JF; Swijgman, HF; Uiterwijk, MM; van Veggel, LM; Vermeeren, A | 1 |
Albizzati, MG; Bassi, S; Borghi, C; Frattola, L; Garreau, M; Morselli, PL; Piolti, R | 1 |
Barki, J; Gineston, JL; Lamblin, G; Larrey, D; Michel, H; Pageaux, G | 1 |
Garreau, M; Morselli, PL; Zivkovic, B | 1 |
Lader, M; Morton, S | 2 |
Albizzati, MG; Bassi, S; Borghi, C; Bottani, MS; Cesana, BM; Frattola, L; Morselli, PL; Piolti, R; Priore, P | 1 |
Morselli, PL | 1 |
Albizzati, MG; Bassi, S; Cesana, B; Farolfi, A; Ferrarese, C; Frattola, L; Piolti, R | 1 |
Casacchia, M; Cesana, B; Farolfi, A; Magni, G; Priore, P; Rossi, A; Stratta, P | 1 |
Csanalosi, I; Rickels, K; Schweizer, E | 1 |
2 review(s) available for alpidem and Anxiety Neuroses
Article | Year |
---|---|
Studies with alpidem in normal volunteers and anxious patients.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Humans; Imidazoles; Pyridines; Reference Values | 1990 |
On the therapeutic action of alpidem in anxiety disorders: an overview of the European data.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Europe; Humans; Imidazoles; Pyridines | 1990 |
7 trial(s) available for alpidem and Anxiety Neuroses
Article | Year |
---|---|
Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Attention; Automobile Driving; Cross-Over Studies; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Imidazoles; Lorazepam; Middle Aged; Naphthyridines; Ondansetron; Piperazines; Psychomotor Performance; Pyridines; Sulfur Compounds | 1995 |
Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imidazoles; Male; Middle Aged; Neurologic Examination; Personality Assessment; Pyridines; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
Topics: Adult; Analysis of Variance; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Electroencephalography; Evoked Potentials, Auditory; Female; Galvanic Skin Response; Humans; Imidazoles; Lorazepam; Male; Memory; Middle Aged; Psychiatric Status Rating Scales; Pyridines; Reaction Time | 1992 |
Effects of alpidem in anxious elderly outpatients: a double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Female; Humans; Imidazoles; Male; Psychiatric Status Rating Scales; Psychomotor Performance; Pyridines | 1992 |
Studies with alpidem in normal volunteers and anxious patients.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Humans; Imidazoles; Pyridines; Reference Values | 1990 |
Alpidem, a novel anxiolytic drug. A double-blind, placebo-controlled study in anxious outpatients.
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Psychomotor Performance; Pyridines; Random Allocation | 1989 |
A double-blind, placebo-controlled study of alpidem, a novel anxiolytic of imidazopyridine structure, in chronically anxious patients.
Topics: Adjustment Disorders; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Chronic Disease; Conversion Disorder; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Pyridines; Randomized Controlled Trials as Topic | 1989 |
3 other study(ies) available for alpidem and Anxiety Neuroses
Article | Year |
---|---|
[Fatal subfulminant hepatitis during treatment with alpidem (Ananxyl)].
Topics: Aged; Anti-Anxiety Agents; Anxiety Disorders; Asthenia; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Humans; Imidazoles; Liver Function Tests; Pyridines | 1993 |
Alpidem from pharmacology to clinic.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Humans; Imidazoles; Pyridines; Receptors, GABA-A | 1992 |
Pilot study of alpidem, a new nonbenzodiazepine anxiolytic, in the treatment of generalized anxiety disorder.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Humans; Imidazoles; Pilot Projects; Pyridines | 1988 |